Cardiac Rhythm Management Devices Batteries Market, By Product Type (Implantable Cardiac Pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Device), By Power Source (Lithium-Iodine Cells, Lithium-Silver Vanadium Oxide Cell, Lithi

Cardiac Rhythm Management Devices Batteries Market, By Product Type (Implantable Cardiac Pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Device), By Power Source (Lithium-Iodine Cells, Lithium-Silver Vanadium Oxide Cell, Lithium-Carbon Monofluride Cells, Lithium-Manganese Dioxide), and by Regions(North America, Europe, Asia Pacific, Latin America, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Battery systems consists of one or more storage batteries and battery chargers, and includes inverters, converters, and associated electrical equipment. As instruments are increasingly becoming computerized and mobile, systems’ performance and reliability depends on its battery. There are three major types of batteries used in medical devices based on their chemical composition, which includes lithium batteries, nickel-metal hydride batteries, and zinc-air batteries. Demand for medical batteries has increased significantly in the recent past, due to advancements in technology in lithium ion batteries for better performance and durability. For instance, in December 2017, Hong Kong-based company, Surwon Technology, has successfully completed the grapheme layering process to conduct energy through lithium-ion battery.
Manufacturers are focusing on manufacturing battery, which can provide high performance and have long-life span. For instance, CONMED launched Hall lithium battery system in 2013, which has double power storage capability than standard batteries and can be used in reconstructive orthopedic procedures for uninterrupted surgery procedure. Furthermore, increasing demand for implantable devices to cater to rising population suffering from chronic diseases such as diabetes and cardiovascular, is expected to aid in high demand for implantable batteries.
Restraints of the Global Cardiac Rhythm Management Device Batteries
However, safety concerns related to lithium batteries is a major factor restraining growth of cardiac rhythm management device batteries market. Lithium rechargeable batteries have the potential to overheat and even catch fire, this can occur due to overcharging, overloading, or by over-stressing due mechanical or environmental pressure.
Key features of the study:
This report provides in-depth analysis of the global cardiac rhythm management device batteries and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global cardiac rhythm management device batteries based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include EaglePicher Technologies, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Greatbatch, Inc. (Integer), Quallion LLC, Medtronic Plc, and St. Jude Medical, Inc.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global cardiac rhythm management device batteries report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Cardiac Rhythm Management Device Batteries, By Product Type:
Implantable Cardiac Pacemaker
Implantable Cardioverter Defibrillator
Cardiac Resynchronization Device
Global Cardiac Rhythm Management Device Batteries, By Power Source:
Lithium-Iodine Cells
Lithium-Silver Vanadium Oxide Cell
Lithium-Carbon Monofluride Cells
Lithium-Manganese Dioxide
Global Cardiac Rhythm Management Device Batteries, By Geography:
North America
By Product Type:
Implantable Cardiac Pacemaker
Implantable Cardioverter Defibrillator
Cardiac Resynchronization Device
By Power Source:
Lithium-Iodine Cells
Lithium-Silver Vanadium Oxide Cell
Lithium-Carbon Monofluride Cells
Lithium-Manganese Dioxide
By Country:
U.S.
Canada
Europe
By Product Type:
Implantable Cardiac Pacemaker
Implantable Cardioverter Defibrillator
Cardiac Resynchronization Device
By Power Source:
Lithium-Iodine Cells
Lithium-Silver Vanadium Oxide Cell
Lithium-Carbon Monofluride Cells
Lithium-Manganese Dioxide
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Implantable Cardiac Pacemaker
Implantable Cardioverter Defibrillator
Cardiac Resynchronization Device
By Power Source:
Lithium-Iodine Cells
Lithium-Silver Vanadium Oxide Cell
Lithium-Carbon Monofluride Cells
Lithium-Manganese Dioxide
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product Type:
Implantable Cardiac Pacemaker
Implantable Cardioverter Defibrillator
Cardiac Resynchronization Device
By Power Source:
Lithium-Iodine Cells
Lithium-Silver Vanadium Oxide Cell
Lithium-Carbon Monofluride Cells
Lithium-Manganese Dioxide
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Product Type:
Implantable Cardiac Pacemaker
Implantable Cardioverter Defibrillator
Cardiac Resynchronization Device
By Power Source:
Lithium-Iodine Cells
Lithium-Silver Vanadium Oxide Cell
Lithium-Carbon Monofluride Cells
Lithium-Manganese Dioxide
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Implantable Cardiac Pacemaker
Implantable Cardioverter Defibrillator
Cardiac Resynchronization Device
By Power Source:
Lithium-Iodine Cells
Lithium-Silver Vanadium Oxide Cell
Lithium-Carbon Monofluride Cells
Lithium-Manganese Dioxide
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
EaglePicher Technologies *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Boston Scientific Corporation
Biotronik SE & Co. KG
Greatbatch, Inc.
Quallion LLC
Medtronic Plc
St. Jude Medical, Inc.
“*” marked represents similar segmentation in other categories in the respective section.